Physician profile
Yasmin Rosshandler
NPI 1689203754
$801.68
in general payments reported to CMS, 2019-2025
14 companies · $757 in 2025
The $757 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $44.41 · 2025: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $109.65 | 2025 | Mounjaro, Zepbound, Jardiance |
| Gilead Sciences, INC. | $100.17 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.11 | 2025 | |
| Novo Nordisk INC | $92.82 | 2025 | Rybelsus, Ozempic, Wegovy |
| Inspire Medical Systems, INC. | $86.61 | 2025 | Inspire |
| Pfizer INC. | $76.89 | 2025 | |
| Exact Sciences Corporation | $62.52 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $38.82 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $36.88 | 2025 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.59 | 2025 | Jardiance |
| Glaxosmithkline, LLC. | $23.96 | 2024 | Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.45 | 2024 | Xifaxan |
| Amgen INC. | $16.67 | 2025 | Otezla, Repatha |
| Merck Sharp & Dohme LLC | $16.54 | 2025 | Capvaxive, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yasmin Rosshandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.